原发性腹膜后肿瘤手术联合放疗应用效果及安全性分析

Analysis of efficacy and safety of radiotherapy combined with radiotherapy for patients with primary retroperitoneal tumor

目的探讨手术联合放射治疗原发性腹膜后肿瘤的效果及其安全性。方法选取该院2012年1月至2014年1月收治的原发性腹膜后肿瘤患者112例作为研究对象,按是否接受术后放射治疗分为联合组(手术联合术后放疗)和对照组(仅单纯接受手术治疗),每组56例。对比分析两组疗效及并发症发生情况。结果联合组经治疗后有效率[80.36%(45/56)]高于对照组[51.79%(29/56)],差异有统计学意义(P<0.05)。联合组总生存率较高,经治疗后无腹腔出血、感染等严重并发症发生,随访显示无肠坏死、输尿管狭窄等远期并发症发生。结论手术联合术后放射治疗原发性腹膜后肿瘤安全、有效,可提高患者生存率。

Objective To investigate the efficacy and safety of surgery combined with radiotherapy for primary retroperitoneal tumor.Methods A total of 112 cases patients with primary retroperitoneal tumor admitted from January 2012 to January 2014 were selected as the subjects.The patients were divided into the combined group(surgery combined with radiotherapy)and the control group(only the surgical treatment),56 cases in each group.The efficacy and complications of the two groups were compared and analyzed.Results The effective rate of the combined group after treatment[80.36%(45/56)]was higher than that of the control group[51.79%(29/56)],the difference was statistically significant(P<0.05).The overall survival rate of the combined group was higher.There were no serious complications such as abdominal bleeding and infection after the treatment.There were no long-term complications such as intestinal necrosis and ureteral stricture.Conclusion Surgical radiotherapy combined with primary peritoneum tumor is safe and effective,and the survival rate of patients can be improved.